Navigation Links
Free Herceptin Treatment for Those Who Live Over the Welsh Border

Royal Shrewsbury Hospital treats people from Shropshire and parts of Wales. Breast cancer patients from England must pay £47,000 to get the wonder drug Herceptin but Welsh women get it for free. //

This discrimination arose when the Primary Care Trust in Shropshire refused to pay for Herceptin for early stage breast cancer sufferers until the drug is licensed. But it is free for the welsh as all Welsh Local Health Boards have agreed to pay for the drug for women living in Wales even if they are treated in England. In one instance four women are being treated from Mid Wales at the 544-bed Shrewsbury hospital.

But Margaret Bradford, 54, who lives in Oswestry, Shropshire two miles from the Welsh border was diagnosed with the most aggressive form of breast cancer but is denied the free drug. She said that the drug has to be given to all those who need it. Hence she and her family had to start a fundraising campaign to pay for her treatment privately. She has now started a year-long course of Herceptin at the Christie Hospital in Manchester.

She is paying to have her treatment in Manchester because the hospital there was able to offer it for £32,000 - £15,000 cheaper than in Shropshire. The Shropshire Six is a group of women who are campaigning to get their PCT to fund the drug. Their campaign is supported by fellow breast cancer sufferer. In another incidence where Susan Morgan, 41, of Coton, Shropshire was denied the free treatment for the same cause is also note worthy. Then her daughter Katie, ten, wrote to North Shropshire Tory MP Owen Paterson pleading with him to help her mother obtain the drug.

Mr Paterson said that it is a very sad plight for the women in Shropshire because despite them regularly paying their tax they had to raise huge sums of money, while women two miles away in Wales are getting the drug in the same hospital for free. The Royal Shrewsbury Hospital is awaiting formal confirmation from the Dyfed Powys Lo
'"/>




Page: 1 2

Related medicine news :

1. Nurse wins her case over use of Herceptin for her Breast cancer
2. Drug Herceptin To Be Recommended To All Breast Cancer Patients
3. Herceptin Is A Possible Cure For Breast Cancer
4. Herceptin Not A ‘Wonder’ Drug, Says The Lanct
5. £6000 to be refunded to Mrs. Leese for Herceptin treatmen
6. Wangaratta Community fundraising for Herceptin drug
7. Herceptin for Early Stage Breast cancer
8. Treatment of Breast Cancer with Herceptin for Nine Weeks
9. Herceptin is the cure for early stages of breast cancer?
10. 10-year-old Pleads, Herceptin For My Mum, Please
11. Norfolk PCTs To Offer Herceptin
Post Your Comments:
(Date:11/20/2008)...v. 20 ReachMD, the first satellite...by medical professionals, announced,today their n...merican Medical,Directors Association (AMDA), the...ttending physicians, and others practicing in the ... Crecelius, President of AMDA says, "ReachMD provi...
(Date:11/20/2008)... Nov. 10 Precision Therapeutics In...g response tests, has secured $43 million,in addi...rcialization of,ChemoFx(R). ChemoFx is a diagnos...fective chemotherapeutic regimen for cancer patien...P., led the round and was joined by existing,inve...
(Date:11/20/2008)...t cancer patients who underwent a mastectomy who u...construction, autologous tissue reconstruction pro...metic results than tissue expander and implant rec...issue of the International Journal of Radiation O...the American Society for Therapeutic Radiology and...
(Date:11/20/2008)...of the brain chemical serotonin may be key, study ...ws) -- Variations in the genetic makeup of alcohol...ggests. , And the key might be the brain,s cont...chemical. , The research could potentially help...f becoming an alcoholic, and then treat that perso...
Breaking Medicine News(10 mins):Health News:ReachMD Announces New Strategic Partnership with American Medical Directors Association 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 2Health News:Precision Therapeutics Secures $43 Million in Venture Capital Funding 3Health News:Type of breast reconstruction impacts radiation therapy outcomes 2Health News:Genetic Trait Linked to Alcoholism 2
... global AIDS epidemic continues to spiral with 4.3...ub-Saharan Africa alone accounting for 65 percent ...DS/WHO 2006 AIDS Epidemic Update released in Genev... million people are living with HIV. Of these, abo...
...ple who eat a lot of onions, garlic and other alli...cer// than those who avoid the pungent herbs, new ... several Italian and Swiss cancer studies to look ...garlic consumption and cancer at several body site...
...ecent communiqué had reported that nearly three fo...ieve// the estimated one-month target of completin...As a reaction to this report, Federal Health Minis...so-called benchmarks and targets set to achieve he...
...nnai: Spiritual leaders, including Sri Sri Ravi Sh...ome together to fight HIV/AIDS, stressing the need...ve million Indians. They discussed HIV/AIDS care, ...e to the stigma and discrimination related to the ...
Other Medicine News:Health News:More then Four Million New HIV Infections in 2006: UNAIDS 2Health News:Onions, Garlic may Reduce the Risk of Cancer 2Health News:Spiritual Leaders Join Together to Fight Against HIV/AIDS in India 2
(Date:11/19/2008)... N.Y., Nov. 19 Biotech scientists ... toxicology research to better understand the effe... systems, reports Genetic Engineering & Biote...sted in figuring out a new compound,s mechanism of...icology technique, according to the November 15 is...
(Date:11/18/2008)...ber 19 NeuroDiscovery Lt...ovider and drug development Company,and Sosei Gr..., a leading,international biopharmaceutical compa...ing further pivotal pre-clinical efficacy data for...tential therapy for neuropathic pain and has,succ...
(Date:11/18/2008)...., Nov. 18 Forty-two le... a November national forum to consider cutting-edg...lth and national economy from outbreaks of dangero...day. , , Among those innovations: , , ...an kitchen table that detects highly contagious an...
(Date:11/13/2008)...Mass., Nov. 13 Hologic, ...cturer and supplier of premium,diagnostics, medica...to,serving the healthcare needs of women, today an...pivotal clinical trial. The Cervista HPV high-risk...U.S. and is expected to be,launched in the Europea...
Breaking Medicine Technology:GEN Reports on the Trend Toward Predictive Toxicogenomics 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 342 Top U.S. Scientists and Specialists Explore Cutting-Edge Innovations to Defend America From Dangerous Zoonotic Diseases 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 2Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 3Hologic Releases the Results of the Cervista(TM) HPV Clinical Trials 4Fires Put Pregnant Women Infants at Risk 4423 1Fires Put Pregnant Women Infants at Risk 4423 2Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 1Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 2Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 3Susan G Komen For The Cure Karmanos Cancer Institute Local Hospitals Call on Policymakers to Address Injustice and Unfairness in Breast Cancer Inci 4421 4Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 1Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 2Oncolytics Biotech Inc Announces Approval for U K Clinical Trial Investigating REOLYSIN 28R 29 in Combination with Cyclophosphamide 1450 3Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 1Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 2Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 3Cephalon Announces Positive Results from Its Pivotal Study of TREANDA in Patients with Non Hodgkins Lymphoma 621 4
...April 11 /CNW/ - Liponex Inc. (TSX:LPX), a,biophar...nced,products related to High Density Lipoprotein ...unced information from further,analysis of the Pha...CRD5 is being developed for the treatment of dysli...patient information indicated that all,blood chemi...
...N FRANCISCO, Calif., April 13, 2007,/PRNewswire-Fi...nounced that the company will present data at the ...cer Research (AACR) being held,April 14-18, 2007 i...in a poster session will focus on,non-clinical dat...tor of cyclin-dependent kinases (CDKs) 2, 7 and 9 ...
Other Medicine Technology:Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 2Liponex Inc. Reports Further Analysis of CRD5 Phase I/II Clinical,Trial Data 3Sunesis Pharmaceuticals to Present Data at the Annual Meeting of,the American Association for Cancer Research 2
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
...is a national reference laboratory and a worldwide...lopment. ARUP offers an extensive test menu of hig...nd anatomic pathology. Owned by the University of ... half of the nation's university teaching hospital...
Medicine Products: